Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN1109382 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Tumor Necrosis Factor (TNF) antibody
- Antibody type
- Monoclonal
- Description
- Ion Exchange Chromatography
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- B-C7
- Vial size
- 0.5 mg
- Storage
- Store the antibody undiluted at 2-8°C.
- Handling
- DO NOT FREEZE!
Submitted references Tetraspanins regulate ADAM10-mediated cleavage of TNF-alpha and epidermal growth factor.
Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea.
Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome.
Pilot clinical trial of an anti-TNF alpha monoclonal antibody for the treatment of septic shock.
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.
Arduise C, Abache T, Li L, Billard M, Chabanon A, Ludwig A, Mauduit P, Boucheix C, Rubinstein E, Le Naour F
Journal of immunology (Baltimore, Md. : 1950) 2008 Nov 15;181(10):7002-13
Journal of immunology (Baltimore, Md. : 1950) 2008 Nov 15;181(10):7002-13
Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea.
Dyugovskaya L, Lavie P, Lavie L
American journal of respiratory and critical care medicine 2003 Jul 15;168(2):242-9
American journal of respiratory and critical care medicine 2003 Jul 15;168(2):242-9
Tumor necrosis factor-alpha and angiostatin are mediators of endothelial cytotoxicity in bronchoalveolar lavages of patients with acute respiratory distress syndrome.
Hamacher J, Lucas R, Lijnen HR, Buschke S, Dunant Y, Wendel A, Grau GE, Suter PM, Ricou B
American journal of respiratory and critical care medicine 2002 Sep 1;166(5):651-6
American journal of respiratory and critical care medicine 2002 Sep 1;166(5):651-6
Pilot clinical trial of an anti-TNF alpha monoclonal antibody for the treatment of septic shock.
Boillot A, Capellier G, Racadot E, Wijdenes J, Herve P, Barale F
Clinical intensive care : international journal of critical & coronary care medicine 1995;6(2):52-6
Clinical intensive care : international journal of critical & coronary care medicine 1995;6(2):52-6
Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.
Hervé P, Flesch M, Tiberghien P, Wijdenes J, Racadot E, Bordigoni P, Plouvier E, Stephan JL, Bourdeau H, Holler E
Blood 1992 Jun 15;79(12):3362-8
Blood 1992 Jun 15;79(12):3362-8
No comments: Submit comment
No validations: Submit validation data